Sinphar Pharmaceutical Co.,Ltd. (TPE:1734)
Taiwan · Delayed Price · Currency is TWD 32.10
0.00 (0.00%)
Sep 24, 2026, 1:30 PM CST
Sinphar Pharmaceutical Market Cap
Sinphar Pharmaceutical has a market cap or net worth of 6.47 billion as of September 25, 2026. Its market cap has increased by 11.38% in one year.
Market Cap
6.47B
Enterprise Value
7.20B
Revenue
3.45B
Ranking
n/a
PE Ratio
18.49
Stock Price
32.10
ChartMarket Cap Chart
Since April 23, 2003, Sinphar Pharmaceutical's market cap has increased from 1.13B to 6.47B, an increase of 475.06%. That is a compound annual growth rate of 7.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 6.47B | 11.56% |
| Dec 31, 2025 | 5.80B | 2.64% |
| Dec 31, 2024 | 5.65B | -0.75% |
| Dec 29, 2023 | 5.69B | 2.41% |
| Dec 30, 2022 | 5.56B | 14.71% |
| Dec 30, 2021 | 4.85B | -6.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Polaris Group | 8.88B |
| Tanvex BioPharma | 8.03B |
| PharmaEngine | 7.97B |
| Locus Cell | 7.70B |
| Adimmune | 7.54B |
| Acepodia | 7.52B |
| AnnJi Pharmaceutical | 7.30B |
| Savior Lifetec | 6.43B |